This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (13)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

EDWIN B. DUNPHY, M.D.; JOSEPH L. DOWLING, Jr., M.D.; ALFRED SCOTT, M.D.

AMA Arch Ophthalmol. 1957;57(4):485-490.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The importance of correctly diagnosing intraocular tumors need not be emphasized. Yet a recent review of 862 eyes submitted to a large pathology department as clinically malignant revealed that 102, or 12%, were found to contain no malignancy.¹ The use of radioactive phosphorus (P³²) to detect malignant ocular tumors has been in vogue at certain ophthalmic centers since 1952. From several papers already published on the subject, it has been definitely shown by radioassay² and by radioautographs³ that malignant tumors concentrate P³² to a greater degree than do other ocular tissues after intravenous injection. Other in vitro and in vivo studies⁴ have demonstrated that this increased uptake can often be detected by a small Geiger counter if this instrument can be placed on the eyeball sufficiently near the tumor area. Furthermore, it has been shown that this increased concentration does not occur in serous . . . [Full Text PDF of this Article]

Author Affiliations
Boston

From the Massachusetts Eye and Ear Infirmary and the Department of Ophthalmology, Harvard Medical School.

Footnotes
Received for publication June 20, 1956.

Aided by a grant from the Barker Foundation and by grants from the Atomic Energy Commission under Contract No. AT(30-1)-1242.

Read before the 92nd Annual Meeting of the American Ophthalmological Society, Hot Springs, Va., June 2, 1956.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?